Urotensin II, mouse

(S)-5-(((4R,7S,10S,13S,16S,19R)-13-((1H-indol-3-yl)methyl)-10-(4-aminobutyl)-16-benzyl-4-(((1S,2S)-1-carboxy-2-methylbutyl)carbamoyl)-7-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-5-oxo-4-((S)-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidylglycyl-L-alanyl-L-alanyl)pyrrolidine-2-carboxamido)pentanoic acid

L-Isoleucine, 5-oxo-L-prolyl-L-histidylglycyl-L-alanyl-L-alanyl-L-prolyl-L-α-glutamyl-L-cysteinyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-tyrosyl-L-cysteinyl-, cyclic (8→13)-disulfide; H-Pyr-His-Gly-Ala-Ala-Pro-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Ile-OH (Disulfide bridge: Cys8-Cys13); L-pyroglutamyl-L-histidyl-glycyl-L-alanyl-L-alanyl-L-prolyl-L-alpha-glutamyl-L-cysteinyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-tyrosyl-L-cysteinyl-L-isoleucine (8->13)-disulfide; Urotensin II (mouse)

≥95%

1.45±0.1 g/cm3

2019.1±65.0°C at 760 mmHg

Pyr-HGAAPECFWKYCI (Disulfide bridge: Cys8-Cys13)

Store at -20°C

Soluble in DMSO

InChI=1S/C76H100N18O19S2/c1-5-40(2)63(76(112)113)93-73(109)58-38-115-114-37-57(91-68(104)52(25-27-62(98)99)86-74(110)59-19-13-29-94(59)75(111)42(4)83-64(100)41(3)82-61(97)36-80-65(101)56(33-46-35-78-39-81-46)90-67(103)51-24-26-60(96)84-51)72(108)88-53(30-43-14-7-6-8-15-43)69(105)89-55(32-45-34-79-49-17-10-9-16-48(45)49)71(107)85-50(18-11-12-28-77)66(102)87-54(70(106)92-58)31-44-20-22-47(95)23-21-44/h6-10,14-17,20-23,34-35,39-42,50-59,63,79,95H,5,11-13,18-19,24-33,36-38,77H2,1-4H3,(H,78,81)(H,80,101)(H,82,97)(H,83,100)(H,84,96)(H,85,107)(H,86,110)(H,87,102)(H,88,108)(H,89,105)(H,90,103)(H,91,104)(H,92,106)(H,93,109)(H,98,99)(H,112,113)/t40-,41-,42-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,63-/m0/s1

CLCYYNXMNPDQEY-QLDMHISLSA-N

O=C(O)CCC(NC(=O)C1N(C(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C2NC(=O)CC2)CC3=CN=CN3)C)C)CCC1)C(=O)NC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(C)CC)CSSC4)CC5=CC=C(O)C=C5)CCCCN)CC6=CNC=7C=CC=CC76)CC=8C=CC=CC8